Impairment of CD4+ T cell polarization by dengue virus-infected dendritic cells

Journal of Infectious Diseases

Volumn 203, Issue 12, 2011, Pages 1763-1774

  Chase, Amanda J ^a   Medina, Freddy A ^b   Muñoz Jordán, Jorge L ^b  

^a GEORGIA COLLEGE AND STATE UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; B7 ANTIGEN; BETA INTERFERON; CD209 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; HLA DR ANTIGEN; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 2;

ARTICLE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; DENDRITIC CELL; DENGUE; DENGUE VIRUS; DENGUE VIRUS 2; DOWN REGULATION; EFFECTOR CELL; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MONOCYTE; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PHYLOGENY; POLARIZATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEROTYPE; SIGNAL TRANSDUCTION; TH1 CELL; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; DENGUE VIRUS; DOWN-REGULATION; GENE EXPRESSION REGULATION, VIRAL; HUMANS; INTERFERON-ALPHA; INTERFERON-BETA; PHYLOGENY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 79957483245     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir197     Document Type: Article

References (46)

1. World Health Organization. Impact of dengue 2010. http://www.who.int/csr/ disease/dengue/impact/en/index.html.
2. Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, Ennis FA. High levels of interferon alpha in the sera of children with dengue virus infection. Am J Trop Med Hyg 1993; 48:222-9. (Pubitemid 23083739)
3. Johnson AJ, Roehrig JT. New mouse model for dengue virus vaccine testing. J Virol 1999; 73:783-6. (Pubitemid 28565427)
4. Shresta S, Kyle JL, Snider HM, Basavapatna M, Beatty PR, Harris E. Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. J Virol 2004; 78:2701-10. (Pubitemid 38314329)
5. Palmer DR, Sun P, Celluzzi C, et al. Differential effects of dengue virus on infected and bystander dendritic cells. J Virol 2005; 79:2432-9. (Pubitemid 40204598)
6. Kurane I, Ennis FA. Production of interferon alpha by dengue virus-infected human monocytes. J Gen Virol 1988; 69(Pt 2):445-9. (Pubitemid 18064171)
7. Diamond MS, Roberts TG, Edgil D, Lu B, Ernst J, Harris E. Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. J Virol 2000; 74:4957-66. (Pubitemid 30313834)
8. Ho LJ, Wang JJ, Shaio MF, et al. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J Immunol 2001; 166:1499-506.
9. Nightingale ZD, Patkar C, Rothman AL. Viral replication and paracrine effects result in distinct, functional responses of dendritic cells following infection with dengue 2 virus. J Leukoc Biol 2008; 84:1028-38.
10. Libraty DH, Pichyangkul S, Ajariyakhajorn C, Endy TP, Ennis FA. Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J Virol 2001; 75:3501-8. (Pubitemid 32246359)
11. Deauvieau F, Sanchez V, Balas C, et al. Innate immune responses in human dendritic cells upon infection by chimeric yellow-fever dengue vaccine serotypes 1-4. Am J Trop Med Hyg 2007; 76:144-54. (Pubitemid 351627817)
12. Sun P, Celluzzi CM, Marovich M, et al. CD40 ligand enhances dengue viral infection of dendritic cells: a possible mechanism for T cell-mediated immunopathology. J Immunol 2006; 177:6497-503. (Pubitemid 44628869)
13. Wu SJ, Grouard-Vogel G, Sun W, et al. Human skin Langerhans cells are targets of dengue virus infection. Nat Med 2000; 6:816-20. (Pubitemid 30469433)
14. Tassaneetrithep B, Burgess TH, Granelli-Piperno A, et al. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med 2003; 197:823-9. (Pubitemid 36437860)
15. Navarro-Sanchez E, Altmeyer R, Amara A, et al. Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep 2003; 4:723-8. (Pubitemid 36974759)
16. Ho LJ, Hung LF, Weng CY, et al. Dengue virus type 2 antagonizes IFN-alpha but not IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell. J Immunol 2005; 174:8163-72.
17. Munoz-Jordan JL, Sanchez-Burgos GG, Laurent-Rolle M, Garcia-Sastre A. Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci USA 2003; 100:14333-8. (Pubitemid 37499237)
18. Munoz-Jordan JL, Laurent-Rolle M, Ashour J, et al. Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol 2005; 79:8004-13. (Pubitemid 40853504)
19. Mazzon M, Jones M, Davidson A, Chain B, Jacobs M. Dengue virus NS5 inhibits interferon-alpha signaling by blocking signal transducer and activator of transcription 2 phosphorylation. J Infect Dis 2009; 200:1261-70.
20. Ashour J, Laurent-Rolle M, Shi PY, Garcia-Sastre A. NS5 of dengue virus mediates STAT2 binding and degradation. J Virol 2009; 83:5408-18.
21. Jones M, Davidson A, Hibbert L, et al. Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression. J Virol 2005; 79:5414-20. (Pubitemid 40548209)
22. Le Bon A, Tough DF. Type I interferon as a stimulus for cross-priming. Cytokine Growth Factor Rev 2008; 19:33-40.
23. Mattei F, Schiavoni G, Tough DF. Regulation of immune cell homeostasis by type I interferons. Cytokine Growth Factor Rev 2010; 21:227-36.
24. Kaech SM, Wherry EJ, Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2002; 2:251-62. (Pubitemid 37323225)
25. Mathew A, Kurane I, Green S, et al. Impaired T cell proliferation in acute dengue infection. J Immunol 1999; 162:5609-15. (Pubitemid 29307175)
26. Rico-Hesse R. Dengue virus virulence and transmission determinants. Curr Top Microbiol Immunol 2010; 338:45-55.
27. Dejnirattisai W, Duangchinda T, Lin CL, et al. A complex interplay among virus, dendritic cells, T cells, and cytokines in dengue virus infections. J Immunol 2008; 181:5865-74.
28. Rodriguez-Madoz JR, Bernal-Rubio D, Kaminski D, Boyd K, Fernandez-Sesma A. Dengue virus inhibits the production of type I interferon in primary human dendritic cells. J Virol 2010; 84:4845-50.
29. Lambeth CR, White LJ, Johnston RE, de Silva AM. Flow cytometry-based assay for titrating dengue virus. J Clin Microbiol 2005; 43:3267-72. (Pubitemid 40981334)
30. Chien LJ, Liao TL, Shu PY, Huang JH, Gubler DJ, Chang GJ. Development of real-time reverse transcriptase PCR assays to detect and serotype dengue viruses. J Clin Microbiol 2006; 44:1295-304.
31. Munoz-Jordan JL, Collins CS, Vergne E, et al. Highly sensitive detection of dengue virus nucleic acid in samples from clinically ill patients. J Clin Microbiol 2009; 47:927-31.
32. Pokidysheva E, Zhang Y, Battisti AJ, et al. Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN. Cell 2006; 124:485-93. (Pubitemid 43199435)
33. Sanchez V, Hessler C, DeMonfort A, Lang J, Guy B. Comparison by flow cytometry of immune changes induced in human monocyte-derived dendritic cells upon infection with dengue 2 live-attenuated vaccine or 16681 parental strain. FEMS Immunol Med Microbiol 2006; 46:113-23.
34. Cologna R, Armstrong PM, Rico-Hesse R. Selection for virulent dengue viruses occurs in humans and mosquitoes. J Virol 2005; 79:853-9. (Pubitemid 40053868)
35. Vasilakis N, Shell EJ, Fokam EB, et al. Potential of ancestral sylvatic dengue-2 viruses to re-emerge. Virology 2007; 358:402-12. (Pubitemid 46138116)
36. Hacker K, White L, de Silva AM. N-linked glycans on dengue viruses grown in mammalian and insect cells. J Gen Virol 2009; 90:2097-106.
37. Braga EL, Moura P, Pinto LM, et al. Detection of circulant tumor necrosis factor-alpha, soluble tumor necrosis factor p75 and interferon-gamma in Brazilian patients with dengue fever and dengue hemorrhagic fever. Mem Inst Oswaldo Cruz 2001; 96:229-32. (Pubitemid 33640932)
38. Azeredo EL, Zagne SM, Santiago MA, et al. Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever. Immunobiology 2001; 204:494-507. (Pubitemid 33138110)
39. Son A, Nakamura H, Okuyama H, et al. Dendritic cells derived from TBP-2-deficient mice are defective in inducing T cell responses. Eur J Immunol 2008; 38:1358-67.
40. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18:767-811. (Pubitemid 30365397)
41. Umareddy I, Tang KF, Vasudevan SG, Devi S, Hibberd ML, Gu F. Dengue virus regulates type I interferon signalling in a strain-dependent manner in human cell lines. J Gen Virol 2008; 89:3052-62.
42. Takhampunya R, Palmer DR, McClain S, et al. Phenotypic analysis of dengue virus isolates associated with dengue fever and dengue hemorrhagic fever for cellular attachment, replication and interferon signaling ability. Virus Res 2009; 145:31-8.
43. Markoff L, Falgout B, Chang A. A conserved internal hydrophobic domain mediates the stable membrane integration of the dengue virus capsid protein. Virology 1997; 233:105-17. (Pubitemid 27348772)
44. Ma L, Jones CT, Groesch TD, Kuhn RJ, Post CB. Solution structure of dengue virus capsid protein reveals another fold. Proc Natl Acad Sci USA 2004; 101:3414-9. (Pubitemid 38338209)
45. McElroy KL, Santiago GA, Lennon NJ, Birren BW, Henn MR, Munoz-Jordan JL. Endurance, refuge, and reemergence of dengue virus type 2, Puerto Rico, 1986-2007. Emerg Infect Dis 2011; 17:64-71.
46. Schneider BS, Higgs S. The enhancement of arbovirus transmission and disease by mosquito saliva is associated with modulation of the host immune response. Trans R Soc Trop Med Hyg 2008; 102:400-8.